Endoxan and malignant neoplasm progression Patient Reports February 12, 2012

Endoxan Side Effects Report #5599694-7
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Female patient, 33 years of age, was diagnosed with t-cell lymphoma stage iv and was treated with Endoxan. After drug was administered, patient experienced the following side effects: dermatitis psoriasiform, malignant neoplasm progression, pancytopenia, pneumonia chlamydial, pyrexia. Endoxan dosage: unknown. During the same period patient was treated with UROMITEXAN, METHOTREXATE, VINDESINE, ADRIAMYCIN PFS, ARANESP, VALACYCLOVIR, BACTRIM, SPECIAFOLDINE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5613774-9
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 28, 2008. Female patient, 33 years of age, was diagnosed with t-cell lymphoma stage iv and was treated with Endoxan. After drug was administered, patient experienced the following side effects: dermatitis psoriasiform, malignant neoplasm progression, pancytopenia, pneumonia chlamydial, pyrexia. Endoxan dosage: unknown. During the same period patient was treated with UROMITEXAN, METHOTREXATE, VINDESINE, ADRIAMYCIN PFS, ARANESP, VALACYCLOVIR, BACTRIM, SPECIAFOLDINE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #4758811-9
Endoxan side effect was reported by a Health Professional from FRANCE on Aug 24, 2005. Female patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: anuria, malignant neoplasm progression, neutropenia, pancytopenia. Endoxan dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINDESINE, ONCOVIN, PREDNISONE, GLEEVEC, GLUCOR, GLUCOPHAGE, GLYBURIDE. Patient died on 08/03/2005.

Endoxan Side Effects Report #5800597-0
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2008. Male patient, 76 years of age, was diagnosed with lymphoma  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: epistaxis, malignant neoplasm progression, small intestinal perforation. Endoxan dosage: unknown. During the same period patient was treated with PREDONINE, VINCRISTINE SULPHATE. Patient died on 11/27/2007.


Endoxan Side Effects Report #5365610-6
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Male patient, 70 years of age, was diagnosed with lymphoma  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, transitional cell carcinoma. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, DOXORUBICIN, FLUDARA, MABTHERA, PEGINTERFERON ALFA, DIAMICRON, STAGID, TICLID. Patient recovered.

Endoxan Side Effects Report #5063084-6
Endoxan side effect was reported by a Health Professional from JAPAN on July 14, 2006. Male patient, 48 years of age, was diagnosed with lymphoma , hiv infection  and was treated with Endoxan. After drug was administered, patient experienced the following side effects: atrial fibrillation , coma, hepatic failure, malignant neoplasm progression, platelet count decreased, somnolence, white blood cell count decreased. Endoxan dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE SULPHATE, LASTET, IFOMIDE, PARAPLATIN, PREDNISOLONE, DECADRON, STOCRIN. Patient was hospitalized. Patient died on 04/29/2005.

Endoxan Side Effects Report #5087640-4
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2006. Male patient, 48 years of age, was diagnosed with lymphoma , acquired immunodeficiency syndrome and was treated with Endoxan. After drug was administered, patient experienced the following side effects: atrial fibrillation , cerebral haemorrhage, coma, hepatic failure, malignant neoplasm progression, platelet count decreased, somnolence, white blood cell count decreased. Endoxan dosage: unknown. During the same period patient was treated with LASTET, IFOMIDE, PARAPLATIN, STOCRIN, ZERIT, ONCOVIN, ADRIAMYCIN PFS, ZEFIX. Patient was hospitalized. Patient died on 04/28/2005.

Endoxan Side Effects Report #5809886-7
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 07, 2008. Male patient, 68 years of age, was diagnosed with interstitial lung disease, off label use, dermatomyositis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: dysphonia, lung squamous cell carcinoma stage iv, malignant neoplasm progression, muscular weakness, respiratory failure. Endoxan dosage: unknown. During the same period patient was treated with PREDNISOLONE, IMMUNE GLOBULIN, PROGRAF. Patient was hospitalized. Patient died on 03/15/2006.

Endoxan Side Effects Report #4653731-2
Endoxan side effect was reported by a Consumer or non-health professional from on Apr 26, 2005. Male patient, 49 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: bradycardia, malignant neoplasm progression, pericardial haemorrhage. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, VINCRISTINE SULPHATE, DOXORUBICIN, CISPLATIN, RITUXIMAB, PREDNISONE, METHYLPREDNISOLONE, CYTARABINE. Patient was hospitalized. Patient died.


Endoxan Side Effects Report #4869539-9
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 02, 2005. Female patient, 53 years of age, was diagnosed with breast cancer recurrent and was treated with Endoxan. After drug was administered, patient experienced the following side effects: alopecia, cardiac failure acute, malignant neoplasm progression, neutropenia, respiratory failure, thrombocytopenia, white blood cell count decreased. Endoxan dosage: unknown. During the same period patient was treated with FARMORUBICIN, HYSRON, MS CONTIN, KYTRIL, DEXAMETHASONE, AREDIA, ENALAPRIL MALEATE, MAGNESIUM OXIDE. Patient died on 11/08/2005.

Endoxan Side Effects Report #4895103-1
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 02, 2005. Female patient, 53 years of age, was diagnosed with breast cancer recurrent and was treated with Endoxan. After drug was administered, patient experienced the following side effects: alopecia, cardiac failure acute, malignant neoplasm progression, neutropenia, respiratory failure, thrombocytopenia, white blood cell count decreased. Endoxan dosage: unknown. During the same period patient was treated with FARMORUBICIN, HYSRON, MS CONTIN, KYTRIL, DEXAMETHASONE, AREDIA, ENALAPRIL MALEATE, MAGNESIUM OXIDE. Patient died on 11/08/2005.

Endoxan Side Effects Report #5263536-X
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2007. Female patient, 63 years of age, was diagnosed with adult t-cell lymphoma/leukaemia, prophylaxis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Endoxan dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, ETOPOSIDE, CARBOPLATIN, METHOTREXATE, PREDNISOLONE, RANIMUSTINE, VINDESINE SULPHATE. Patient died on 12/01/2005.

Endoxan Side Effects Report #5267561-4
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2007. Female patient, 63 years of age, was diagnosed with adult t-cell lymphoma/leukaemia, prophylaxis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Endoxan dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, ETOPOSIDE, CARBOPLATIN, METHOTREXATE, PREDNISOLONE, RANIMUSTINE, VINDESINE SULPHATE. Patient died on 12/01/2005.

Endoxan Side Effects Report #4668260-X
Endoxan side effect was reported by a Physician from on Apr 22, 2004. Female patient, 73 years of age, was treated with Endoxan. After drug was administered, patient experienced the following side effects: bone disorder, bone pain, fistula , jaw disorder, malignant neoplasm progression, oral soft tissue disorder, osteitis, osteomyelitis, osteonecrosis . Endoxan dosage: unknown. During the same period patient was treated with DEXAMETHASONE, HEPARIN, VINCRISTINE, MELPHALAN, CYCLOPHOSPHAMIDE, PREDNISOLONE, VUMON, THALIDOMIDE. Patient recovered.


Endoxan Side Effects Report #4911177-3
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2005. Male patient, 52 years of age, was treated with Endoxan. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia, lung disorder, lymphadenopathy, malignant neoplasm progression, sepsis , thrombocytopenia. Endoxan dosage: unknown. During the same period patient was treated with ADRIBLASTINE, ONCOVIN, HALDOL, TRANXENE, PARKINANE, MOPRAL, SOLUPRED, TOPALGIC. Patient was hospitalized. Patient died.

Endoxan Side Effects Report #4947040-1
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2005. Male patient, 52 years of age, was treated with Endoxan. After drug was administered, patient experienced the following side effects: febrile neutropenia, lung disorder, malignant neoplasm progression, sepsis . Endoxan dosage: unknown. During the same period patient was treated with ADRIBLASTINE, ONCOVIN, HALDOL, TRANXENE, PARKINANE, OMEPRAZOLE, SOLUPRED, TOPALGIC. Patient was hospitalized. Patient died.